D17N (p.Asp17Asn) variant of EPHA3 (Ephrin type-A receptor 3)

D17N (p.Asp17Asn) in EPHA3 (Ephrin type-A receptor 3) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.05 / 1. The record also includes population frequency data and structural context.

D17N (p.Asp17Asn) variant details